Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Andrew Weber, MS
ViiV Healthcare
Disclosure(s): GSK: Stocks/Bonds (Public Company); ViiV Healthcare: Employee
Poster(s):
(P-574) Extrapolating Expected Efficacy, Safety, and Pharmacokinetics (PK) of Dolutegravir/Lamivudine (DTG/3TC) in Pregnant People Living with HIV-1 from Pregnancy Data with Combination DTG and/or 3TC Antiretroviral Therapies
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
